FAKTOR OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Delayed Deutsche Boerse AG 08:35:15 28/06/2024 pm IST | ||
| 800.6 EUR | -9.36% |
|
| Current month | -20.61% | ||
| 1 month | -9.80% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 800.6 | -9.36% |
| 27/24/27 | 883.2 | +17.67% |
| 26/24/26 | 750.6 | -4.10% |
| 25/24/25 | 782.7 | -0.62% |
| 24/24/24 | 787.6 | -9.31% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 08:35 pm IST
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PC8SMY |
| ISIN | DE000PC8SMY8 |
| Date issued | 28/10/2022 |
| Strike | 41.51 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1,352 € |
|---|---|
| Lowest since issue | 41.01 € |
| Spread | 9.05 € |
| Spread % | 1.16% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.51
USD
Average target price
53.19
USD
Spread / Average Target
+28.15%
- Stock Market
- Certificates
- Certificat
